On July 22, 2014, the House considered H.R. 4450 and passed the legislation with a roll call vote of 347 - 57.
Hearing on “21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication,” Subcommittee on Health (July 22, 2014)
The Subcommittee on Health held a hearing on Tuesday, July 22, 2014, at 3:00 p.m. in 2322 Rayburn House Office Building. The hearing was entitled “21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication.”
Today Rep. Henry A. Waxman and Rep. Jan Schakowsky released statements in reaction to the final report of the Chronic Hazard Advisory Panel on Phthalates, convened by the Consumer Product Safety Commission.
Rep. Waxman Statement on President Obama’s Nomination of Jeff Baran to the Nuclear Regulatory Commission
Energy and Commerce Committee Ranking Member Henry A. Waxman issued the following statement on the announcement that President Obama has nominated Jeff Baran to serve as a Commissioner on the Nuclear Regulatory Commission (NRC): “Jeff is a wonderful pick. He’s an exceptionally capable consensus-builder. He listens to all sides, studies the facts, and finds creative...
Hearing on “21st Century Technology for 21st Century Cures,” Subcommittees on Communications and Technology and Health (July 17, 2014)
The Subcommittee on Communications and Technology and the Subcommittee on Health held a joint hearing on Thursday, July 17, 2014, at 9:30 a.m. in 2123 Rayburn House Office Building. The hearing was titled “21st Century Technology for 21st Century Cures.”
Hearing on “Review of CDC Anthrax Lab Incident,” Subcommittee on Oversight and Investigations (July 16, 2014)
The Subcommittee on Oversight and Investigations held a hearing on Wednesday, July 16, 2014, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing was titled “Review of CDC Anthrax Lab Incident.”
Hearing on “Failure to Verify: Concerns Regarding PPACA’s Eligibility System,” Subcommittee on Health (July 16, 2014)
The Subcommittee on Health held a hearing on Wednesday, July 16, 2014, at 10:15 a.m. in 2322 Rayburn House Office Building. The hearing was titled “Failure to Verify: Concerns Regarding PPACA’s Eligibility System.”
On July 15, 2014, the House considered H.R. 5021 under provisions of the rule H.Res. 669. The legislation passed with a roll call vote of 367 - 55.
Today Ranking Members Henry A. Waxman, Anna G. Eshoo, and Diana DeGette sent a letter to John Roth, Inspector General of the Department of Homeland Security (DHS), requesting an investigation into allegations of anti-competitive conduct by Motorola in the sale of public safety telecommunications’ equipment and services.
Full Committee Markup of "H.R. 4771, H.R. 4250, H.R. 594, H.R. 669, H.R. 4290, H.R. 4450, and H.R. 5057," (July 14-15, 2014)
The Committee on Energy and Commerce began a markup on Monday, July 14, 2014. The Committee considered the following: • H.R. 4771, Designer Anabolic Steroid Control Act; • H.R. 4250, Sunscreen Innovation Act, as amended; • H.R. 594, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014, as amended; • H.R. 669, Sudden...